Orthofix to Participate in RBC Capital Markets Health Care Conference
Posted on: Friday, 8 December 2006, 09:01 CST
Orthofix International N.V., (NASDAQ:OFIX) announced today that it is scheduled to participate in the upcoming RBC Capital Markets Health Care Conference.
Matt Lyons, CEO of the recently acquired Blackstone Medical, Inc., will participate in a panel discussion on Motion and Fusion- The Future of Spinal Surgery on Wednesday, December 13th at The Westin New York at Times Square. The panel discussion is scheduled to begin at 1:30 PM Eastern, and a live audio webcast will be available on the company's website at www.orthofix.com.
Orthofix International, N.V., a global diversified orthopedic products company, offers a broad line of minimally invasive surgical, and non-surgical, products for the Spine, Reconstruction, and Trauma health care sectors that address the lifelong bone-and-joint health needs of patients of all ages--helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, including Breg, Inc. and Blackstone Medical, Inc., and via partnerships with other leading orthopedic product companies including Kendall Healthcare. In addition, Orthofix is collaborating in R&D partnerships with leading medical institutions such as the Orthopedic Research and Education Foundation, Rutgers University, the Cleveland Clinic Foundation, and National Osteoporosis Institute. For more information about Orthofix, please visit www.orthofix.com.
Source: Business Wire
Related Articles
- Hospitals, Healthcare Providers to Save With Premier's New General Orthopedic Trauma Products Agreements
- HealthpointCapital to Acquire Ideal Medical Products
- Obagi Medical Products' New Study Shows CLENZIderm M.D. Is Clinically Effective in the Treatment of Acne at Both Once- and Twice-Daily Dosing
- U.S. Demand for Nanotechnology Medical Products to Approach $53 Billion in 2011
- Obagi Medical Products to Present at the Roth Capital Partners 19th Annual OC Conference
- Obagi Medical Products and Syneron to Study Effect of Obagi's Skin Care System As an Adjunct to Aesthetic Procedures
- Obagi Medical Products, Inc. Launches CLENZIderm M.D. Penetrating Acne Therapeutic System
- Utah Medical Products, Inc. Announces Filing a Request for Reconsideration With HHS
- NASDAQ Sends Utah Medical Products, Inc. Notice of Failure to Satisfy Continued Listing Standard
- Utah Medical Products' Claim Denied By HHS
User Comments (0)

RSS Feeds